Skip to main content

Peer Review reports

From: Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling

Original Submission
26 Mar 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 May 2013 Reviewed Reviewer Report - Ratna Vadlamudi
9 May 2013 Reviewed Reviewer Report - Rakesh Kumar
16 May 2013 Author responded Author comments - Mahitosh Mandal
Resubmission - Version 3
16 May 2013 Submitted Manuscript version 3
20 May 2013 Reviewed Reviewer Report - Ratna Vadlamudi
25 May 2013 Reviewed Reviewer Report - Rakesh Kumar
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
31 May 2013 Editorially accepted
3 Jun 2013 Article published 10.1186/1471-2407-13-273

You can find further information about peer review here.

Back to article page